Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review

July 2019 | 52 pages | ID: S68ED1751EBEN
GlobalData

Abstracts

Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, inflammation and others; OTC ophthalmic products; anti-allergy ophthalmic products; and medical devices such as intraocular lenses (IOLs) and others. Santen operates through group companies in Asia, Europe and the US. The company’s R&D activities focus on the development of ophthalmic treatments. Santen is headquartered in Kita-ku, Osaka, Japan.

Santen Pharmaceutical Co Ltd Key Recent Developments

Jun 26,2019: OXB and Santen to develop gene therapy products for retinal disease
Jun 13,2019: Santen’s commitment to ophthalmology underlined by strong preliminary data and symposia detailing the latest in glaucoma and dry eye disease management at SOE 2019
May 09,2019: Santen reports fiscal 2018 consolidated performance
Mar 06,2019: Santen announces selection and launch of its gene therapy drug research and development project for inherited ocular disease treatment for the cyclic innovation for clinical empowerment (CiCLE) program
Mar 06,2019: Santen announces selection and launch of its photo-crosslinking research and development project for pathologic myopia treatment for the cyclic innovation for clinical empowerment (CiCLE) program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Santen Pharmaceutical Co Ltd - Key Facts
Santen Pharmaceutical Co Ltd - Key Employees
Santen Pharmaceutical Co Ltd - Major Products and Services
Santen Pharmaceutical Co Ltd - History
Santen Pharmaceutical Co Ltd - Company Statement
Santen Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Santen Pharmaceutical Co Ltd - Business Description
Business Segment: Medical Devices
Overview
Performance
Business Segment: OTC Pharmaceuticals
Overview
Performance
Business Segment: Others
Performance
Business Segment: Prescription Pharmaceuticals
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: Japan
Performance
Geographical Segment: US
Performance
R&D Overview
Santen Pharmaceutical Co Ltd - Corporate Strategy
Santen Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Santen Pharmaceutical Co Ltd - Strengths
Santen Pharmaceutical Co Ltd - Weaknesses
Santen Pharmaceutical Co Ltd - Opportunities
Santen Pharmaceutical Co Ltd - Threats
Santen Pharmaceutical Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Santen Pharmaceutical Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jun 26, 2019: OXB and Santen to develop gene therapy products for retinal disease
Jun 13, 2019: Santen’s commitment to ophthalmology underlined by strong preliminary data and symposia detailing the latest in glaucoma and dry eye disease management at SOE 2019
May 09, 2019: Santen reports fiscal 2018 consolidated performance
Mar 06, 2019: Santen announces selection and launch of its gene therapy drug research and development project for inherited ocular disease treatment for the cyclic innovation for clinical empowerment (CiCLE) program
Mar 06, 2019: Santen announces selection and launch of its photo-crosslinking research and development project for pathologic myopia treatment for the cyclic innovation for clinical empowerment (CiCLE) program
Nov 07, 2018: Santen reports consolidated results for Q2 fiscal 2018
Sep 12, 2018: Santen Pharmaceutical announce personnel changes of representative Director of the Board
Jul 17, 2018: Santen Donates to Japan Flood and Landslide Relief Efforts
Jun 04, 2018: Santen Announces Medium-Term Plan (MTP2020)
May 09, 2018: Santen Reports Fiscal 2017 Consolidated Performance

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Santen Pharmaceutical Co Ltd, Key Facts
Santen Pharmaceutical Co Ltd, Key Employees
Santen Pharmaceutical Co Ltd, Major Products and Services
Santen Pharmaceutical Co Ltd, History
Santen Pharmaceutical Co Ltd, Other Locations
Santen Pharmaceutical Co Ltd, Subsidiaries
Santen Pharmaceutical Co Ltd, Key Competitors
Santen Pharmaceutical Co Ltd, Ratios based on current share price
Santen Pharmaceutical Co Ltd, Annual Ratios
Santen Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Santen Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Santen Pharmaceutical Co Ltd, Interim Ratios
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Santen Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Santen Pharmaceutical Co Ltd, Performance Chart (2015 - 2019)
Santen Pharmaceutical Co Ltd, Ratio Charts
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Taisho Pharmaceutical Holdings Co Ltd
Senju Pharmaceutical Co Ltd
Mitsubishi Tanabe Pharma Corp
Hoya Corp
Daiichi Sankyo Co Ltd
Chugai Pharmaceutical Co Ltd
Astellas Pharma Inc
Aqumen Biopharmaceuticals
Alcon Japan Ltd